Ball In Judge’s Court In Combination Product Classification Suit
This article was originally published in The Pink Sheet Daily
Executive Summary
All the planned briefs have been filed in a case, Prevor v. United States Food and Drug Administration, that could have important implications for how FDA designates a product for either device or drug primary review.
You may also be interested in...
FDA Final Guidance On Drug/Device Classifications Misses The Mark, Attorneys Say
The final guidance adds some requested clarifications, but does not appear to address the US agency's tendency to designate products as drugs over devices, industry attorneys argue.
Combo Product Classification Guidance Doesn't Fix All Existing Problems, Experts Say
US FDA's tendency to designate products as drugs over devices may remain despite clarifications offered in final guidance.
Combination Product Designations At US FDA Need Faster Appeals, Petition Says
No sponsor is named in the citizen petition, but it was filed on behalf of an applicant that has had a designation-decision appeal "under consideration" for 18 months and counting.